User profiles for Ana I Cubas-Atienzar

Ana I Cubas Atienzar

Liverpool School of Tropical Medicine
Verified email at lstmed.ac.uk
Cited by 756

[HTML][HTML] Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis

…, DE Kirwan, AI Cubas Atienzar… - PLoS neglected …, 2021 - journals.plos.org
Background Individuals infected with SARS-CoV-2 develop neutralising antibodies. We
investigated the proportion of individuals with SARS-CoV-2 neutralising antibodies after …

[HTML][HTML] Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2

AI Cubas-Atienzar, K Kontogianni, T Edwards… - Scientific reports, 2021 - nature.com
In the context of the coronavirus disease 2019 (COVID-19) pandemic there has been an
increase of the use of antigen-detection rapid diagnostic tests (Ag-RDT). The performance of Ag-…

[HTML][HTML] Saliva alternative to upper respiratory swabs for SARS-CoV-2 diagnosis

…, ER Adams, AI Cubas-Atienzar - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
PCR of upper respiratory specimens is the diagnostic standard for severe acute respiratory
syndrome coronavirus 2 infection. However, saliva sampling is an easy alternative to nasal …

[HTML][HTML] Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2

…, CT Williams, AI Cubas-Atienzar… - The Journal of …, 2022 - Am Soc Clin Investig
Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

[HTML][HTML] Self-sampling of capillary blood for SARS-CoV-2 serology

…, RL Byrne, A Fraser, SI Owen, AI Cubas-Atienzar… - Scientific reports, 2021 - nature.com
Serological testing is emerging as a powerful tool to progress our understanding of COVID-19
exposure, transmission and immune response. Large-scale testing is limited by the need …

[HTML][HTML] IgG seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection

…, RL Byrne, M Cocozza, AI Cubas-Atienzar… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated the dynamics of seroconversion in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …

Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections

…, Y Augustin, RL Byrne, M Cocozza, AI Cubas-Atienzar… - MedRxiv, 2020 - medrxiv.org
We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …

[HTML][HTML] A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing

…, G Hayward, E Cook, AI Cubas-Atienzar… - PloS one, 2022 - journals.plos.org
Background Rapid diagnostic tests (RDTs) developed for point of care detection of SARS-CoV-2
antigen are recommended by WHO to use trained health care workers to collect …

Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration

…, RL Byrne, DJ Clark, M Cocozza, AI Cubas-Atienzar… - MedRxiv, 2020 - medrxiv.org
Here we describe an open and transparent consortium for the rapid development of COVID-19
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …

[HTML][HTML] Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

…, L Brown, RL Byrne, AM Collins, AI Cubas-Atienzar… - Journal of Infection, 2022 - Elsevier
Background There are an abundance of commercially available lateral flow assays (LFAs)
that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer…